Cost-Effectiveness of Venetoclax-Based Treatment in Treatment-Naïve Fit Patients With CLL Without TP53 Aberrations. - Ehlers LH; Levin MD; van der Klift M; Jensen MB; Tran HTT; Kater AP; Niemann CU (European journal of haematology, 2026)